Loading stock analysis…
Evidence Synthesis
Last synthesized: 20 Oct 2026, 10:43
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
Vasuprada Sees Significant Improvement in Gross Margin and Marginal Operating Leverage.
The company's gross margin accelerated to , up from -1.53%. This represents a quarterly increase of 53.25 points. Additionally, the marginal operating leverage improved, moving from -2.68% to -1.53%, up by 0.43 points.
In terms of trading activity, the daily volume decreased to 40 shares, down from 113 shares, a decline of 0.513 shares. The close price remained flat at 100 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 79.94 % | -1.53 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -1.53 % | -2.68 | ▲ |
| REVENUE_GROWTH_YOY | 16.3 % | — | - |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 40 shares | 113 | ▼ |
| CLOSE_PRICE | 100 INR | 100 | - |
Cite this
Source: Samhati evidence synthesis for VASUPRADA (2026-10-20). Observation: Vasuprada Sees Significant Improvement in Gross Margin and Marginal Operating Leverage. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/vasuprada
Filing step-changes